Ribomic Inc

NEW
TSE:4591 (Japan)  
円 59 +1 (+1.72%) Jun 26
At Loss
P/B:
1.13
Market Cap:
円 3.30B ($ 20.65M)
Enterprise V:
円 473.80M ($ 2.96M)
Volume:
152.60K
Avg Vol (2M):
540.56K
Trade In:
Volume:
152.60K
At Loss

Business Description

Description
Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.
Name Current Vs Industry Vs History
Cash-To-Debt
No Debt
Equity-to-Asset
0.96
Piotroski F-Score
3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
13.03
Distress
Grey
Safe
Beneish M-Score
-1.18
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
38.32
9-Day RSI
35.25
14-Day RSI
33.86
3-1 Month Momentum %
-24.21
6-1 Month Momentum %
-4
12-1 Month Momentum %
-29.41

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
21.68
Quick Ratio
21.66
Cash Ratio
20.93
Days Sales Outstanding
67.89

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-15
Shareholder Yield %
-27.92

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin %
-40237.73
Net Margin %
-38178.67
EBITDA Margin %
-40104.57
FCF Margin %
-37367.67
OCF Margin %
-37028.77
ROE %
-37.67
ROA %
-36.06
ROIC %
-1367.79
3-Year ROIIC %
-4342.9
ROC (Joel Greenblatt) %
-12339.92
ROCE %
-39.7

Financials

TSE:4591's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Ribomic Inc Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil 円) 3
EPS (TTM) (円) -23.07
Beta -0.0926
3-Year Sharpe Ratio -0.95
3-Year Sortino Ratio -1.15
Volatility % 31.61
14-Day RSI 33.86
14-Day ATR (円) 2.898189
20-Day SMA (円) 62.7
12-1 Month Momentum % -29.41
52-Week Range (円) 57 - 127
Shares Outstanding (Mil) 55.95

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Ribomic Inc Filings

Filing Date Document Date Form
No Filing Data

Ribomic Inc Stock Events

Financials Calendars
Event Date Price (円)
No Event Data

Ribomic Inc Frequently Asked Questions

What is Ribomic Inc(TSE:4591)'s stock price today?
The current price of TSE:4591 is 円59.00. The 52 week high of TSE:4591 is 円127.00 and 52 week low is 円57.00.
When is next earnings date of Ribomic Inc(TSE:4591)?
The next earnings date of Ribomic Inc(TSE:4591) is .
Does Ribomic Inc(TSE:4591) pay dividends? If so, how much?
Ribomic Inc(TSE:4591) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Ribomic Inc

No articles.